Delivery Order SPE2DB24D9638-SPE2DB24FEKPB

This is a delivery order for LINZESS 72 MCG CAPSULE UU 30S awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The order has a ceiling value of $14,469.12 and is a firm-fixed price contract with an ultimate completion date of August 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, is supplying this medication product through an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued up to $999,999,999 and runs through...

The Defense Logistics Agency awarded a $399.60 delivery order to Amerisourcebergen Drug Corporation for 4561412468 LINZESS 72 MCG CAPSULE UU 30S. The firm fixed price order is being fulfilled under the Prime Vendor Program and will provide 30 capsules of the specified medication to support DLA's medical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 5-6, 2023. No subcontractors or set aside designations were...

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LINZESS 145 MCG CAPSULE UU 30S, a medication, with a firm fixed price ceiling value of $2,093.79 and a completion date of June 12, 2025. The contract is not set-aside and was awarded on June 11, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a significant...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,548.04 fixed-price contract is for the supply of LINZESS 145 MCG CAPSULE UU 30S, a prescription medication, with a performance period ending on June 18, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA...

This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,295.19 firm-fixed-price delivery order is for the supply of 4565297640 - LINZESS 72 MCG CAPSULE UU 30S, a pharmaceutical product, with a period of performance through July 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a...

The Defense Logistics Agency awarded a $4,010.46 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562178011 LINZESS 72 MCG CAPSULE UU 30S. The prime contractor Amerisourcebergen Drug Corporation, operating from its Conshohocken, Pennsylvania location, will deliver the specified pharmaceutical product to the Defense Logistics Agency by September 15, 2023 in support of the agency's medical supply needs. No additional subcontractors or set aside designations were...

This federal contract award is for the delivery of LINZESS 290 MCG CAPSULE UU 30S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $3,383.24 and is a firm fixed-price delivery order, with an ultimate completion date of August 13, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This award is not associated with a larger indefinite delivery/indefinite quantity (ID/IQ) vehicle, and...

<p>Defense Logistics Agency awarded a $804 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, on October 18, 2023. To be performed in Conshohocken, Pennsylvania, the order is for 4562520233 LINZESS 72 MCG CAPSULE UU 30S with an estimated completion date of October 19, 2023. No set-aside designation was used for this requirement to deliver LINZESS capsules in support of DLA programs.</p>

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of LINZESS 290 MCG capsules, with a ceiling value of $7,472.64 and a period of performance through March 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through...

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corporation, for the supply of LINZESS 145 MCG Capsule in a 30-count size. The contract has a total ceiling value of $5,942.11 and is a firm fixed-price contract type. The ultimate completion date for the contract is September 6, 2024. This award is not associated with any set-aside designation. AmerisourceBergen, through its Corporate Office...